INS and Abdominal obesity: Negatively influences insulin signaling, then enhances insulin resistance.Increases inflammation by stimulation of the production of pro-inflammatory cytokines.Contributes to various components of metabolic syndrome development, including hypertension, dyslipidemia, and abdominal obesity.